Rezvan Najafi

ORCID: 0000-0003-1326-1288 · 6 papers in corpus · active 2016-2022
2022
Biotechnology letters ·doi:10.1007/s10529-021-03209-8

It only took 8 months for the pneumonia caused by a previously unknown coronavirus to turn into a global pandemic of unprecedentedly far-reaching implications. Failure of the already discovered treatment measures opened up a new opportunity…

2020
Cell biology international ·doi:10.1002/cbin.11367

Adaptor protein containing a PH domain, PTB domain and leucine zipper motif 1 (APPL1) plays a central role as the main contributing factor in the adiponectin and insulin signaling. This review aims to discuss previous and recent findings co…

2017
Cell proliferation ·doi:10.1111/cpr.12315

ObjectivesStem cell therapy is considered to be a suitable alternative in treatment of a number of diseases. However, there are challenges in their clinical application in cell therapy, such as to reduce survival and loss of transplanted st…

2017
Biotechnology letters ·doi:10.1007/s10529-016-2214-0

ObjectivesTo investigate the effect of AdipoRon on major factors involved in survival, migration and neovascularization of rat bone marrow-derived mesenchymal stem cells.ResultsAdipoRon promoted the MSCs viability. Real-time PCR indicated t…

2017
Journal of cellular biochemistry ·doi:10.1002/jcb.25816

Objectivecolorectal cancer (CRC) is one of the most common malignancies, associated with high rates of relapse. A notable challenge in treatment is low response rate to current therapies for advanced CRC. The miR-200c plays an essential rol…

2016
Clinical and experimental pharmacology & physiology ·doi:10.1111/1440-1681.12590

Stem cell-based therapies is a promising approach for regenerative therapy in various diseases. Some obstacles remain to be solved before clinical application of the cell therapy is realized, including increasing the survival of transplante…